Corning Incorporated will build a high-volume Valor Glass manufacturing facility that will create over 300 new jobs in Durham County, North Carolina According to company officials, its Valor Glass dramatically reduces particle contamination, breaks and cracks while significantly increasing throughput. As a result, Valor helps protect patients and improves pharmaceutical manufacturing.Adding capacity for Valor Glass in Durham is part of Corning’s plan to invest $500 million and create 1,000 new U.S. jobs. The announcement follows similar Corning investments in the development and manufacturing of Valor Glass in Big Flats and Erwin, New York.The new facility will be constructed adjacent to a Corning Life Sciences manufacturing facility, enabling the company to realize synergies between the two businesses. It is anticipated the new facility will be operational by year-end 2019.“Making this next-generation product requires a new, advanced manufacturing platform. We are proud to build this high-volume manufacturing facility for Valor Glass in Durham County,” said Wendell P. Weeks, Corning’s Chairman, CEO & President.“This progress is made possible by great customers like Merck and Pfizer, and the strong support that we have received from Senator Burr, Governor Cooper and the Durham County Commissioners, the White House Office of American Innovation, and FDA’s Emerging Technology Team,” Weeks said.“We have been part of the Valor program since its outset and we are thrilled to take part in today’s ceremony which celebrates the outstanding progress in the development of this remarkable product. This technology is a critical advancement in pharmaceutical packaging,” said Sanat Chattopadhyay, Executive Vice President & President, Merck Manufacturing Division.This latest announcement demonstrates Corning’s commitment to bringing Valor to patients and healthcare practitioners. “We are proud to have partnered with Corning to advance this revolutionary new glass for medicines that are critical to patients. Our ongoing testing at several of our major sterile injectable U.S. manufacturing sites continues to show promise, and we continue to work with Corning to assess the full potential of this new, innovative glass,” said Kirsten Lund-Jurgensen, Executive Vice President & President, Pfizer Global Supply."I'm pleased to see North Carolina continue to lead the way in the research and development of innovative products to save and improve lives," said U.S. Senator Richard Burr, of North Carolina. "This leadership continues to result in new job opportunities in our state and improve healthcare across the country. I am proud to participate in this dedication as a part of this work."